Summary: The role of nitric oxide (NO) in the mediation of cerebrovascular CO2 responsiveness was studied in 10 distinct brain and spinal cord regions of the anesthetized, ventilated, temperature-controlled, normoxic cat. Re gional CBF was measured with 15-f.Lm radiolabeled mi crospheres in hypocapnic, normocapnic, and hypercap nic conditions. CO2 responsiveness of each region was determined from the equation of the best-fit regression lines to the obtained flow values. The effect of altered endothelial and/or neuronal NO synthesis on CO2 respon siveness was studied following either selective blockade of the NO synthase enzyme by N"'-nitro-L-arginine methyl ester (L-NAME; 3 or 30 mg/kg i.v.) or simulta neous administration of L-NAME (3 mg/kg i.v.) and a large dose of the NO precursor L-arginine (30 mg/kg i.v.). it functions as a small, lipophilic, chemically unsta ble molecule, sparingly soluble in aqueous medium, which rapidly diffuses through all types of biologi cal membrane barriers (Ignarro, 1989 (Ignarro, , 1990 Abbreviations used: L-NAME, NW-nitro-L-arginine methyl es ter; rCBF, regional CBF; rSBF, regional spinal cord blood flow.
in a significant reduction of the steady-state regional blood flow values and in an almost complete abolition of the CO2 sensitivity in each region studied. Changes of the basal flow values as well as the reduction of the regional CO2 sensitivity were dose dependent. Hypothalamic, sensorimotor cortical, and cerebellar regions were the ar eas most sensitive to the NO blockade. Impaired CO2 responsiveness following NO synthase inhibition, how ever, was reversed in these regions by simultaneous ad ministration of a large dose of intravenously injected L-ar ginine. These findings suggest a major role of nitric oxide in the mediation of regional cerebrovascular CO2 respon siveness in cats. Key Words: L-Arginine-Cerebral blood flow-C02 responsiveness-Endothelium-derived relax ing factor-Nitric oxide-Nitric oxide synthase-Spinal cord blood flow.
precursor, L-arginine (Palmer et aI., 1988 a,b) , can be found throughout the intra-and extracellular compartments of the body. The Ca 2 + -dependent enzyme NO synthase, which forms NO from L-ar ginine, has been found in the vascular endothelium (Knowles et aI., 1989; Moncada et aI., 1989) and in the tissue of the vertebrate forebrain and cerebel lum (Bredt and Snyder, 1989 ; Knowles et aI., 1989) as well as in the perivascular nerves (Bredt et aI., 1990 ) and astrocytes (Murphy et aI., 1990) . Although NO is a very small and highly diffusible molecule, the extent of its transcellular communi cation is limited by the fact that it has an ultra-short half-life (estimated to be <5 s in biological tissues), and its diffusion distance during this time is in the range of 50-100 /.Lm. The responses to NO, there fore, are likely to be regional, localized responses (Ignarro, 1990) . In the present study, it was hypoth esized that nitric oxide might mediate one of the most characteristic reactions of the cerebrovascular bed: CO2-induced vasodilation. Since the previ ously mentioned data suggest that cerebrovascular effects of NO are more likely to be localized than generalized, this study was focused on the effect of NO (or, more precisely, the effect of NO synthase inhibition) on regional cerebral and spinal CO2 re sponsiveness. Iadecola (1992) , Wang et al. (1992) , and Pelligrino et al. (1993) recently reported loss of CO2 reactivity by nitroarginine in the rat. The studies of Adachi et al. (1992) and Sokoloff et al. (1992) , however, did not support a role of nitric oxide in CO2-induced cerebral vasodilation in this same species. In the present study, (a) the effect of NO synthase inhibi tion on cerebral and spinal vascular CO2 respon siveness was studied in another species-the cat; (b) the relationship between the dose of the NO synthase inhibitor and the magnitude of its effect on CO2 responsiveness was evaluated; and (c) the question of whether or not the different brain and spinal cord regions respond differently to arterial Pco2 alterations following NO synthase blockade was analyzed in a systematic manner.
MATERIALS AND METHODS

Animal preparation
Twenty-six male cats (2.0-3.8 kg) were utilized in this study. The animals were anesthetized with an initial dose of intraperitoneally injected chloralose (50 mg/kg) and urethane (300 mg/kg). The anesthesia was maintained with successive intravenous injections of the anesthetics in compliance with the recommendation of the American Heart Association Ethics Committee. The animals were artificially ventilated by a respirator (Harvard Dual Phase Control Pump) through an endotracheal cannula with room air, supplemented with 0.3-0.5 Llmin 100% O2, The temperature of the animals was kept constant at 37°C by using a rectal thermometer (YSI model 73a) and a servo controlled heating lamp. Catheters were inserted into the right brachial and femoral arteries (for blood gas deter mination and for reference radioactivity sampling), into the left femoral artery [for continuous blood pressure monitoring on a polygraph (Grass model 7E)], into the left femoral vein (for drug injection), and into the left ventri cle of the heart (for radiolabeled microsphere administra tion). Heparin was administered intravenously in a dose of 500 units/kg.
Measurement of regional CBF
Regional CBF (rCBF) and regional spinal cord blood flow (rSBF) were determined with radiolabeled micro spheres using the reference sample method (Marcus et aI., 1976) . The microspheres, 15 ± 1.5 fLm in diameter (DuPont, NEN-TRAC), were dissolved in 0.9% saline with 0.0 1% Tween-80 and were injected into the left ven tricle of the heart, in a volume of 0.3-0.5 ml, with an activity of 40 fLCi. The vials containing the microspheres were vigorously shaken by an electric shaker before the injections to ensure even dispersion of the microspheres.
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The micro spheres e4lCe, 85Sr, 95Nb) were injected over a lO-s period for each measurement of flow in an amount that allowed �500 microspheres to be delivered to 1 g of cerebral tissue. The injection was followed by a lO-s flush of 2.0 ml of saline. Reference blood samples were col lected via a femoral and brachial artery using a Harvard withdrawal syringe pump at a speed of 1.0 ml/min, begin ning 30 s prior to the injection and continuing for 2 min after the saline flush. (The pump speed was controlled with an accuracy of 0.00 1 ml/min.) The microsphere in jection did not alter arterial blood pressure or heart rate. At the end of the experiments, the cats received an over dose of intravenously injected Nembutal, and the brain was infused via the carotid artery with 10% buffered for malin. After removing the brain from the skull, the fol lowing discrete areas of the brain were cut and placed in 5-ml vials: thalamus, hypothalamus (mediobasal area, in cluding the median eminence), pituitary (neuro-and ade nohypophysis together with the stalk), white matter (cor pus callosum), frontoparietal cortex (midsuprasylvian and midectosylvian gyri), cerebellum (vermis), pons medulla oblongata (nucleus tractus solitarii region), and cervical, thoracic, and lumbar spinal cord (coronal sec tions, gray and white matter together). The tissue samples were weighed and counted in a gamma scintillation spec trometer (Packard model MINAXI "I, Auto-gamma 5000 series). The energy windows used for 141Ce, 85Sr, and 95Nb were 120-180, 460-560, and 700-800 keY, respec tively. Back-scatter from isotopes with higher energy into windows of lower energy emission was subtracted to ob tain a corrected count value. CBF was calculated from the following equation:
where rCBF is regional CBF (ml g-I min -I), Cb is counts/l g brain tissue, RBF is reference arterial blood sample withdrawal rate (ml/min), and Cr is total counts in the reference arterial blood sample.
Calculation of regional CO2 responsiveness
Regional cerebrovascular CO2 responsiveness was tested by measuring the local CBF and SBF values of 10 distinct cerebral and spinal cord regions at normal, at decreased, and at increased arterial P ac02 values. The increase of CBF under the influence of elevated Pac02 can be best characterized by a sigmoidal curve when viewed over a large range of P ac02 changes (Reivich, 1964; Olesen et aI., 1971) . Most authors, however, suc cessfully fit a straight regression line to their experimental data when the P ac02-CBF relationship is studied in the range of 25-65 mm Hg P ac02' In the present study, this latter method was used since the normocapnic flow val ues (at 36-38 mm Hg P aC02) as well as the hypocapnic flow values (at 25-28 mm Hg P aC02) and the hypercapnic flow values (at 50-60 mm Hg P aC02) obtained in the study were measured in the "straight-line" range of the sigmoi dal curve. Hypocapnia was obtained by increasing the rate of the respiration and hypercapnia was produced by 5% CO2 gas inhalation. The rCBF and rSBF measure ments at each P ac02 level were performed after a period of at least 10 min at the desired Pac02 level (monitored with a continuous end-tidal CO2 recording) to ensure that after each P ac02 change, a new steady state was attained.
Pa02 was kept in a normoxic range (above 100 mm Hg) during the entire time of the experiments to avoid any unwanted interference of a hypoxic component with the obtained results.
Regional cerebral and spinal CO2 responsiveness was expressed from the equation of the slope of the best-fit regression line as milliliters blood flow change per gram brain tissue per minute per I-mm Hg change of p.coz.
Protocol
The experiments were performed in four groups, each consisting of six or seven cats. The cats in Group I (con trols) received only the vehicle (2 mllkg saline i. v. over I min) in which the NO synthase blocker NW-nitro-L arginine methyl ester (L-NAME) or the NO precursor L-arginine was dissolved. Group 2 was treated with 3 mg/ kg i.v. L-NAME. Group 3 received 30 mg/kg i.v. L-NAME. Group 4 received a combination of 3 mg/kg i.v. L-NAME and 30 mg/kg i.v. L-arginine followed by a con tinuous lO-mg/kg/min i. v. L-arginine infusion. rCBF and rSBF were first measured in each group at normocapnia, 30 min after the vehicle or drug injection. After this, hy percapnia was induced by COz inhalation, and when steady state had been reached, the flow measurement was repeated. Thereafter, COz inhalation was stopped and hy pocapnia was induced by increasing the rate of respira tion, and in the new steady-state conditions, the rCBF rSBF measurement was repeated.
Drugs
The NO synthase blocker L-NAME hydrochloride, the NO precursor L-arginine hydrochloride, and the anesthet ics urethane (urethane ethyl carbamate) and chloralose
were purchased from Sigma. All chemicals were dis solved in physiological saline. Heparin sodium was ob tained from Elkins-Sinn (Cherry Hill, NJ, U.S.A.).
Statistical analysis
Regional COz responsiveness of the cerebral and spinal vessels was calculated from the best-fit regression line to the three consecutive flow values obtained in each animal during normocapnic, hypocapnic, and hypercapnic conditions. The slopes of the regression lines were deter mined by a computer program using the least-squares principle. CO2 responsiveness was expressed in milliliters blood flow per gram brain tissue per minute per I-mm Hg increase of P .coz. Each of the four experimental groups consisted of either six or seven cats, and the individual regression coefficients for the animals in each of the four groups were compared statistically by using the one-way analysis of variance to assess the overall significance of group differences. As post hoc tests, Duncan's multiple range test, the Scheffe t test, and the Newman-Keuls test were applied. The level of statistical significance was set at 0.05 in all evaluations.
RESULTS
Effect of NO synthase inhibition on steady-state arterial pressure, rCBF, and rSBF L-NAME administration resulted in all experi ments in a rise of the systemic mean arterial pres sure immediately following drug administration. P a02 was adjusted to a normoxic value (112 ± 10-128 ± 21 mm Hg), Paco2 was kept in a normocapnic range (35.8 ± 0.9-38.0 ± 1.4 mm Hg), and arterial pH was set between 7.21 and 7.30 by adjusting the respiratory rate and by bicarbonate administration in all experiments before drug administration ( Table  l) . Under our experimental conditions and at this range of arterial blood gases, the elevation of the MABP of the 3 mg/kg L-NAME-treated cats (129 ± 39 mm Hg) and that of the 30 mg/kg L-N AME treated cats (139 ± 31 mm Hg) were not signifi cantly different from the MABP values observed either in the saline-treated control group (123 ± 25 mm Hg) or in the combined L-NAME (3 mg/kg) plus L-arginine (30 mg/kg)-treated group (123 ± 32 mm Hg; see Table 3 ). TABLE 1. Effect of intravenously administered saline, L-NAME, and L-NAME + L-arginine on steady-state arterial pressure, blood gases, and regional CBF in anesthetized cats L-NAME L-NAME L-NAME (3 mg/kg) + Saline (3 Regional CBF (rCBF) values are expressed in ml g-I min -I (mean ± SD). No. of animals in the different groups: saline, n = 6; NW-nitro-L-arginine methyl ester (L-NAME) 3 mg/kg, n = 7; L-NAME 30 mg/kg, n = 6; L-NAME 3 mglkg + L-arginine 30 mg/kg, n = 7. a p < 0.05 compared with the saline-treated control value.
The administration of 3 mg/kg L-NAME (Table 1 ) caused no significant changes in the steady-state rCBF and rSBF values in the majority of the inves tigated regions, except in the pituitary (where flow was reduced by -50%). Administration of 30 mg/kg L-NAME, however, resulted in a significant reduc tion of the flow in all but two regions. The flow reduction did not reach the level of statistical sig nificance in the cortex or the white matter. Steady state flow values in the 3 mg/kg L-NAME-treated group and those of the combined 3 mg/kg L-NAME plus 30-mg/kg L-arginine-treated groups were al most identical. The only exception to this was found in the pituitary, where the high dose of L-ar ginine coadministration resulted in a reversal of the L-NAME-induced flow reduction. 15  20  25  30  35  40  45  50  55  60  65  70   PaC02·mmHg   CEREBELLUM   15  20  25  30  35  40  45  so  55  60  65  70 PaC02.mmHg on the details of this observation. The first one is that the reduction of the cerebral and spinal CO2 sensitivity by NO synthase inhibition is a dose dependent phenomenon: CO2 sensitivity was less reduced when a smaller dose of L-NAME (3 mg/kg) was administered. The other fact shown in this table is that the same dose of the NO synthase inhibitor (3 mg/kg) had a differential influence on the different brain and spinal cord regions. Regional cerebrovas cular CO2 sensitivity was significantly reduced after this smaller dose of L-NAME in the cortex, cere bellum, and hypothalamus; it was not significantly affected by the same dose of L-NAME in the thal amus, in the medulla oblongata, in the spinal areas, and in the white matter; and an inverse relationship was observed between flow and P aco2 in the pitu itary.
Effect of L-arginine on regional CO2 responsiveness following NO synthase inhibition by L-NAME
To study whether or not the effect of NO syn thase inhibition on CO2 responsiveness can be an tagonized competitively by a large dose of the NO precursor L-arginine, one group of cats (n = 7) re- ceived 30 mg/kg L-arginine immediately after 3 mgl kg L-NAME administration and then a continuous 10 mg/kg/min L-arginine infusion was sustained dur ing the whole study. Since the sensorimotor cortex, cerebellum, hypothalamus, and pituitary were af fected the most when 3 mg/kg L-NAME was admin istered alone (Table 2) , the competitive influence of the L-arginine (i. e., the recovery fr om the TABLE 2. Dose-dependent reduction of regional cerebrovascular CO2 sensitivity following NO synthase inhibition by L-NAME and recovery following simultaneous L-NAME and L-arginine treatment L-NAME L-NAME L-NAME (3 mg/kg) + Saline (3 mg/kg) (30 mg/kg) L-arginine (30 mg/kg) Values are expressed as means ± SD. abs, ml g-l min-1 blood flow change per I-mm Hg change in Paco2; %, CO2 sensitivity expressed as percent of that of the saline-treated controls as 100%. No. of animals in the different groups: saline, n = 6; 3 mg/kg N"'-nitro-L-arginine methyl ester (L-NAME), n = 7; 30 mg/kg L-NAME, n = 6; 3 mg/kg L-NAME + 30 mg/kg L-arginine, n = 7. a p < 0.05 compared with the saline-treated control value.
L-NAME-induced reduction of CO2 responsive ness) was expected mainly in these regions. Figure   3 shows that the 3 mg/kg L-NAME-induced signifi cant diminution of the CO2 responsiveness resulted in a statistically significant recovery in the cortical, cerebellar, and hypothalamic vessels following the high dose of L-arginine.
DISCUSSION
The main goal of this study was to examine the hypothesis that nitric oxide, identified as an endo thelium-derived relaxing factor, plays an important role in the CO2-induced alterations of CBF and SBF in the cat. The dose-response relationship between the dose of NO synthase blocking agent L-NAME and its effect on regional cerebrovascular CO2 sen sitivity was also examined. Since the effects of NO can be expressed over small regions, the role played by NO in CO2 sensitivity was investigated in 10 distinct brain and spinal cord regions, and not in the cerebrovascular bed as a whole. induced hypocapnic reduction of CBF in pentobar bital-anesthetized rabbits (measured with radiola beled micro spheres) was not significantly modified by the NO synthase inhibitor � -nitro-L-arginine in the studies of Faraci and Heistad (1992) . This may be due to the low flow values produced without the blocker present such that any fu rther reduction in the presence of the blocking agent would be difficult to observe. This was seen in the present studies as well. Saito et al. (1993) concluded that NO plays a modulatory role in the cerebral vasculature, but it is not essential for COz reactivity in anesthetized, par alyzed dogs. The data published by Sokoloff et al. (1992) are the only information currently available on the effect of NO synthase blockade on cerebro vascular COz sensitivity in unanesthetized animals. The question arises of whether or not it is the use of anesthesia that is responsible for the reduced vas cular reactivity to COz fo llowing NO synthase blockade. This is, however, unlikely since Adachi et al. (1992) obtained the same results in urethane anesthetized rats as Sokoloff et al. (1992) did in un anesthetized rats. One may also speCUlate that the type of anesthetics and the use of muscle relaxants are the main causes of the decreased COz respon siveness fo llowing NO blockade in the studies of Iadecola (1992) , Wang et al. (1992) , and Pelligrino et al. (1993) . In all three studies, the animals were anesthetized the same way (inhalation anesthesia), with the same anesthetic agent (halothane), and were paralyzed by either tubocurarine or suxame thonium. The present study, however, arrived at the very same conclusion as Iadecola, Wang et al., and Pelligrino et al., although the anesthesia was induced in a different way (intraperitoneally) by dif fe rent anesthetic agents (chloralose and urethane) and in a different state of neuromuscular transmis sion (without using muscle relaxants). Another pos sible explanation of the obvious discrepancies be tween the results obtained by the different groups of investigators is the species difference. It is difficult to explain, however, why Adachi et al. (1992) , Sokoloff et al. (1992) , and Irikura et al. (1993) fo und completely different results than did Iadecola (1992), Pelligrino et al. (1993) , and Ngai et al. (1993) in the very same species. The same is true when comparing the data of the present article with those of Amano et al. (1993) , who also used chloralose/ urethane-anesthetized cats. In the work of Amano et al., however, different cerebrovascular parame ters were measured (pial vessel diameter and cere bral blood volume), a different NO synthase blocker was used ( � -monomethyl-L-arginine) in a different way (intracarotid injection or topical ap plication) with different timing (during COz inhalation, so that the time for a more complete NO blockade was limited). The use of different NO syn thase inhibitors cannot explain these discrepancies, since Adachi et al. used the same blocking agents as Wang et al., and Sokoloff et al. used the same blocking agents as Pelligrino and co-workers (L NAME). An important fa ctor, however, which may contribute to the contradictory results, is the time that elapsed between the injection of the blocking agents and the flow measurements, as emphasized by Morita-Tsuzuki et al. (1993) . They fo und in anes thetized rats that L-NAME-induced reduction of cerebrocortical flow increase fo llowing sphenopala tine parasympathetic nerve stimulation was clearly dependent on the time elapsed between L-NAME administration and the nerve stimulation. In the other investigations mentioned, it is not always clear how much time elapsed between the injection of the NO synthase inhibitors and the flow measure ments. In the present study, the effect of altered P aCoZ on rCBF was studied at least 30 min after NO synthase blockade. Another finding of the present work is that the reduction of the regional cerebral and spinal cord COz responsiveness fo llowing NO synthase inhibi tion is a dose-related process: The smaller the dose of L-NAME administered to the cats, the smaller the reduction of regional COz responsiveness. Fur thermore, the administration of a smaller dose of the NO synthase inhibitor led to the observation of differential regional effects. The dose of 3 mg/kg L-NAME caused no change in the COz sensitivity of the white matter, the spinal areas, the medulla ob longata, and the thalamus. This same dose, how ever, caused a significant reduction of the COz re sponsiveness in the cortex, cerebellum, hypothala mus, and pituitary (Table 2 ). These data indicate that the role played by NO in cerebrovascular COz responsiveness is different fr om region to region. One possible explanation of this regionally different effect of the NO synthase inhibition is that different amounts of the enzyme are present in different brain or spinal cord regions. Regions with a small amount of NO synthase will be affected by a low dose of the enzyme inhibitor, whereas those with a higher concentration of the enzyme will not. Histo chemical mapping of the distribution of nitric oxide synthase in the cat's brain is not yet available. The same type of mapping, however, in the rat brain shows that the regional differences in the NO syn thase concentration are significant in this species. According to the data of Forstermann et al. (1990) , the cerebellum has the highest NO synthase activity in the rat's brain. Vincent and Kimura (1992) fo und a major cell group in the hypothalamic area strongly stained with NADPH-diaphorase in this species. They came to the conclusion that NO synthase may play an important role in the cerebral cortical func tion as well. They were able to identify, however, only some moderately stained neurons in the paraventricular nucleus of the thalamus. These data were obtained in a different species, with a different a � esthesia than in the present study. It is of interest to observe, however, that in spite of the obvious differences, regional alterations of CO2 responsive ness following NO synthase blockade observed in the present study in cats show some correlation with the regional NO synthase activity observed in the previously mentioned studies in rats. A role of some nonspecific effects of the high dose of L-NAME cannot be ruled out completely in the present studies since recent data of Buxton et al. (1993) indicate a muscarinic antagonist effect of L-NAME in rabbit coronary artery and in canine colonic smooth muscle preparations. The observa tion, however, that the 3 mg/kg L-NAME-induced significant reduction of the regional CO2 respon siveness was almost completely restored by a high dose of L-arginine in the cerebral cortex and in the cerebellar and hypothalamic regions suggests that the changes in regional cerebral and spinal CO2 sen sitivity following L-NAME administration are direct consequences of an impaired NO synthesis.
NO synthase inhibition results in a significant re duction of the steady-state rCBF values not only after L-NAME administration, but also following � -nitro-L-arginine treatment, as was shown by Kovach et al. (1992) in the same species under the same anesthesia. The question arises of whether the regional differences in the steady-state rCBF and rSBF values following L-NAME administration may determine in some way the extent of the re duction of the CO2 responsiveness in those regions. This is, however, unlikely since the basal flow value did not change uniformly following 3 mg/kg L-NAME administration in the regions in which CO2 sensitivity was highly affected by the NO blockade (i.e., in the cortex, cerebellum, and hypo thalamus) (Table 1 ). It is unlikely that reduced re gional CO2 sensitivity following NO synthase block ade could be explained simply by the simultaneous elevation of the systemic arterial pressure. This view is supported by two facts: First, systemic ar terial pressure increase following L-NAME admin istration was not statistically significant under our experimental conditions (Table 3) . Second, admin istration of 3 mg/kg L-NAME resulted in a signifi cant depression of the CO2 reactivity of some re gions (cortex, hypothalamus, and cerebellum), but caused no such changes at the same time at the TABLE 3. Systemic MABP values fo llowing saline, L-NAME, and simultaneous L-NAME + L-arginine treatment under normocapnic, hypocapnic, and hypercapnic conditions in anesthetized cats L-NAME (3 mg/kg) + L-NAME L·NAME L·arginine Saline (3 mg/kg) (30 mg/kg) (30 mg/kg) (n = 6) (n = 7) (n = 6) (n = 7) Values are means ± SD expressed as mm Hg. n = no. of animals. L·NAME, NW-nitro·L-arginine methyl ester. No statis tically significant difference was found either within the groups at different Paco21evels or among the groups at the same Paco2 level.
same arterial pressure level in some other regions (white matter, thoracic and lumbar spinal cord). This view is in agreement with the data of Wang et al. (1992) who found that depressed CO2 reactivity caused by � -nitro-L-arginine could not be ex plained by the associated rise in blood pressure in anesthetized rats.
The exact mechanism by which NO participates in the CO2-induced cerebral vasodilation is not yet clear. Since endothelial damage did not influence CO2 responsiveness of the pial vessels in the rat (Gotoh et aI., 1987) or that of the isolated cerebral arteries of the dog (Toda et aI., 1989) , it is more likely that it is the neuronally produced NO that plays a role in cerebrovascular CO2 responsiveness. There is a continuing debate on the role of the CO2-induced pH changes in cerebral vasodilation and hypercapnic flow increase. Some authors conclude that although pH changes may contribute to cere brovascular regulation, they are neither of major importance nor prerequisites for dilation to occur (Siesj6, 1984) . Others posit that hypercapnic cere bral vasodilation is related to CO2-induced pH changes in and around the smooth muscles (Gotoh et aI., 196 1; Lassen, 1968; Wahl et aI., 1970; Kuschinsky and Wahl, 1978) . Both views may find common ground, however, if it is not the acid in tracellular pH per se that mediates CO2-induced va sorelaxation, but the consequent increase of neuro nal NO production. Experimental evidence has shown that acid pH increases NO synthase activity and in this way stimulates NO production in cere bellar tissue (Heinzel et aI., 1992) . The recent study of Niwa et al. (1993) provided evidence that cere brocortical flow increase induced by loc a l extracel lular acidosis was significantly reduced by N''' -nitro L-arginine superfusion. It is likely, therefore, that CO2-induced cerebral vasodilation is mediated at least in part by NO. Pelligrino et ai. (1993) suggest that increased H + levels during hypercapnia may affect Ca 2 + availability, and altered Ca 2 + availabil ity may also play a role in hypercapnic vasodilation, since calcium is required for activation of both the constitutive NO synthase enzyme and the enzyme initiating the cascade of the prostanoid synthesis: phospholipase A2• The fact that the amount of the available precursor molecule for NO production (L arginine) may be different regionally, temporally, and under different conditions, and the amount and activity of the NO synthase enzyme may also change in time, may vary from region to region, and may be depressed or stimulated by several factors, may provide a reasonable explanation for the dis crepancies regarding the role of pH in the control of the cerebral vascular diameter.
